SR
Seelam Ravindranath Reddy
About Seelam Ravindranath Reddy
Data last updated:
Seelam Ravindranath Reddy has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Esha Kurnool Diagnostics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Esha Kurnool Diagnostics Private Limited at ₹2.44 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 02 Dec 2024 | 2021 | ₹2.44 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Seelam Ravindranath Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seelam Ravindranath Reddy
Seelam Ravindranath Reddy has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Esha Kurnool Diagnostics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Esha Kurnool Diagnostics Private Limited at ₹2.44 Cr (FY 2025).
Seelam Ravindranath Reddy is associated with 1 company as Managing Director, including Esha Kurnool Diagnostics Private Limited (₹2.44 Cr).
Seelam Ravindranath Reddy has expertise in General Business.
Seelam Ravindranath Reddy has 1 years in corporate governance.
By reported revenue, the largest current company of Seelam Ravindranath Reddy is Esha Kurnool Diagnostics Private Limited, with revenue of ₹2.44 Cr (FY 2025).
Seelam Ravindranath Reddy currently holds positions at 1 company: Esha Kurnool Diagnostics Private Limited (₹2.44 Cr).